- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 1.74M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $0 |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $0 |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $540.62K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $631.7K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $905K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.06M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $10.54M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $8.79M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $12.28M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $10.62M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 702.57K sh |
| Capex | Q1 2025 · Mar 31, 2024 | $19.99K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.23M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $3.04M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.96M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$5.93 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$5.93 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $10.84K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$4.16M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$4.16M |
| Revenue | Q1 2025 · Mar 31, 2024 | $15.93K |